Belpointe Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-5,371
| Closed | -$745K | – | 872 |
|
2024
Q1 | $745K | Buy |
+5,371
| New | +$745K | 0.06% | 343 |
|
2023
Q3 | – | Sell |
-1,744
| Closed | -$224K | – | 672 |
|
2023
Q2 | $224K | Sell |
1,744
-1,549
| -47% | -$199K | 0.02% | 542 |
|
2023
Q1 | $383K | Buy |
3,293
+467
| +17% | +$54.3K | 0.02% | 654 |
|
2022
Q4 | $320K | Buy |
2,826
+77
| +3% | +$8.72K | 0.02% | 707 |
|
2022
Q3 | $222K | Sell |
2,749
-151
| -5% | -$12.2K | 0.02% | 788 |
|
2022
Q2 | $216K | Buy |
2,900
+80
| +3% | +$5.96K | 0.01% | 796 |
|
2022
Q1 | $361K | Buy |
2,820
+1,516
| +116% | +$194K | 0.02% | 650 |
|
2021
Q4 | $176K | Sell |
1,304
-44
| -3% | -$5.94K | 0.01% | 946 |
|
2021
Q3 | $184K | Sell |
1,348
-508
| -27% | -$69.3K | 0.01% | 886 |
|
2021
Q2 | $198K | Buy |
+1,856
| New | +$198K | 0.01% | 840 |
|
2020
Q3 | – | Sell |
-4,000
| Closed | -$406K | – | 791 |
|
2020
Q2 | $406K | Buy |
+4,000
| New | +$406K | 0.05% | 342 |
|